Facilitators and barriers to establishing lactation among women with diabetes?
McGuinness D, Daniel U, Brien DO
Diabet Med. 2025:e70045.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Comparative efficacy of different functional hydrogel dressings in healing diabetic foot ulcer: a systematic review and network meta-analysis
Zhou X, Chen S, Savitz B, et al.
Diabetes Obes Metab. Pub. online 8 Apr 2025.
Leggi
M120 risk score improves identification of children at high risk of developing clinical type 1 diabetes and reports short-term response to preventive immunotherapy
Le MV, Harrison LC, Spelman T, Wentworth JM
Diabetes Care. 2025:dc242794.
Leggi
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
Ostrominski JW, Højbjerg Lassen MC, Claggett BL, et al.
Eur Heart J. 2025;46(14):1321-1331.
Leggi
Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies
Thomsen RW, Mailhac A, Løhde JB, Pottegård A
Diabetes Obes Metab. Pub. online 8 Apr 2025.
Leggi
Effect of marked weight loss on adipose tissue biology in people with obesity and type 2 diabetes
Samovski D, Smith GI, Palacios H, et al.
Diabetes Care. 2025:dc242739.
Leggi
Comparative efficacy and tolerability of currently approved incretin mimetics: a systematic analysis of placebo-controlled clinical trials
Kang YM, Punov V, Lim S, Nauck MA
Diabetes Obes Metab. Pub. online 11 Apr 2025.
Leggi
Latres E, Plum-Moerschel L, Murugesan SMN, et al. Diabetes Obes Metab. Pub. online 10 Apr 2025.
O’Hara DV, Jardine MJ
Diabetes Obes Metab. Pub. online 8 Apr 2025.
Leggi
An open-label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
Latres E, Plum-Moerschel L, Murugesan SMN, et al.
Diabetes Obes Metab. Pub. online 10 Apr 2025.
Leggi
Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
Böhm M, Butler J, Coats A, et al.
Eur Heart J. 2025;46(14):1304-1317.
Leggi